Edition:
India

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

193.02USD
8 May 2020
Change (% chg)

$0.03 (+0.02%)
Prev Close
$192.99
Open
$193.01
Day's High
$193.38
Day's Low
$191.64
Volume
4,208,109
Avg. Vol
1,314,681
52-wk High
$202.22
52-wk Low
$114.27

Latest Key Developments (Source: Significant Developments)

Abbvie Says Saw Modest Impact To New Patient Starts For Some Drugs Due To COVID-19 Restrictions: Q1 Conf Call
Friday, 1 May 2020 

May 1 (Reuters) - Abbvie Inc ::ABBVIE INC SAYS SAW MODEST IMPACT TO NEW PATIENT STARTS FOR SOME DRUGS DUE TO COVID-19 RESTRICTIONS IN Q1: CONF. CALL.ABBVIE INC CEO SAYS EXPECTS PRONOUNCED IMPACT ON ALLERGAN’S AESTHETICS BUSINESS DUE TO COVID-19: COF. CALL.ABBVIE INC CEO SAYS EXPECTS ALLERGAN'S BOTOX AESTHETICS BUSINESS TO REBOUND QUICKLY AFTER INITIAL IMPACT DUE TO COVID-19: CONF. CALL.ABBVIE INC EXPECTS U.S. HUMIRA SALES GROWTH OF ABOUT 7% IN 2020: CONF. CALL.ABBVIE CEO SAYS U.S. HUMIRA SALES FORECAST FOR 2020 ASSUMES MORE PATIENTS WILL SHIFT TO MEDICAID PLANS.  Full Article

Allergan Declares Q1 Cash Dividend Of $0.74 Per Ordinary Share
Friday, 24 Jan 2020 

Jan 24 (Reuters) - Allergan plc ::ALLERGAN DECLARES FIRST QUARTER 2020 CASH DIVIDEND OF $0.74 PER ORDINARY SHARE.ALLERGAN PLC - BOARD DECLARED A CASH DIVIDEND OF $0.74 PER ORDINARY SHARE FOR Q1 OF 2020.  Full Article

Allergan Announces Launch Of SkinMedica Eye Cream
Friday, 17 Jan 2020 

Jan 17 (Reuters) - Allergan plc ::ALLERGAN PLC - ANNOUNCED LAUNCH OF SKINMEDICA INSTANT BRIGHT EYE CREAM.  Full Article

BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpt
Friday, 27 Dec 2019 

Dec 27 (Reuters) - BTL AESTHETICS::BTL AESTHETICS - CO'S U.S. AFFILIATE FILED LAWSUIT AGAINST ALLERGAN PLC, IRELAND & ITS AFFILIATES, ZIMMER MEDIZINSYSTEME GMBH, GERMANY & ITS AFFILIATE.BTL AESTHETICS- LAWSUIT ASSERTS THAT COOLTONE DEVICE, MANUFACTURED BY ZIMMER FOR ALLERGAN, INFRINGES ON BTL'S U.S. PATENTS.BTL AESTHETICS - IS SEEKING AN INJUNCTION AND MONETARY DAMAGES.BTL AESTHETICS - LAWSUIT INTENDED TO PREVENT ALLERGAN FROM IMPORTING & SELLING COOLTONE SYSTEMS IN THE U.S..BTL- ALLERGAN'S COOLSCULPTING, WHEN USED BEFORE, OR AFTER COOLTONE THERAPY, INFRINGES ON BTL'S U.S. PATENT FOR THERAPEUTIC APPLICATION OF 2 TECHNOLOGIES.BTL AESTHETICS - LAWSUIT INTENDED TO PREVENT ALLERGAN FROM MARKETING COOLTONE ALONE OR IN CONJUNCTION WITH COOLSCULPTING THERAPY.  Full Article

Allergan Receives U.S. FDA Approval For Ubrelvy For Acute Treatment Of Migraine With Or Without Aura In Adults
Tuesday, 24 Dec 2019 

Dec 23 (Reuters) - Allergan plc ::ALLERGAN RECEIVES U.S. FDA APPROVAL FOR UBRELVY™ FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS.ALLERGAN PLC - UBRELVY HAS BEEN APPROVED WITH TWO DOSE STRENGTHS, 50 MG AND 100 MG.  Full Article

U.S. FDA Says Granted Approval Of Ubrelvy To Allergan USA
Tuesday, 24 Dec 2019 

Dec 23 (Reuters) - U.S. FDA::U.S. FDA - APPROVED UBRELVY TABLETS FOR ACUTE (IMMEDIATE) TREATMENT OF MIGRAINE WITH/WITHOUT AURA (A SENSORY PHENOMENON/VISUAL DISTURBANCE) IN ADULTS.FDA - GRANTED APPROVAL OF UBRELVY TO ALLERGAN USA, INC.FDA SAYS UBRELVY IS NOT INDICATED FOR PREVENTIVE TREATMENT OF MIGRAINE.  Full Article

Third Point Reports Share Stake In Afya Ltd, SmileDirectClub
Friday, 15 Nov 2019 

Nov 14 (Reuters) - Third Point LLC::THIRD POINT LLC REPORTS SHARE STAKE OF 400,000 CLASS A SHARES IN AFYA LTD - SEC FILING.THIRD POINT LLC DISSOLVES SHARE STAKE IN CHEMOURS CO - SEC FILING.THIRD POINT LLC TAKES SHARE STAKE OF 3.6 MILLION SHARES IN ALLERGAN PLC - SEC FILING.THIRD POINT LLC DISSOLVES SHARE STAKE IN MARATHON PETROLEUM CORP - SEC FILING.THIRD POINT LLC REPORTS SHARE STAKE OF 750,000 CLASS A SHARES IN SMILEDIRECTCLUB INC - SEC FILING.THIRD POINT LLC CUTS SHARE STAKE IN PAYPAL HOLDINGS INC BY 22.9% TO 2.7 MILLION SHARES - SEC FILING.THIRD POINT LLC - CHANGE IN HOLDINGS ARE AS OF SEPTEMBER 30, 2019 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF JUNE 30, 2019.  Full Article

Allergan Declares Q4 Cash Dividend Of $0.74 Per Ordinary Share
Friday, 25 Oct 2019 

Oct 25 (Reuters) - Allergan plc ::ALLERGAN DECLARES FOURTH QUARTER 2019 CASH DIVIDEND OF $0.74 PER ORDINARY SHARE.  Full Article

Abbvie And Allergan Receive Second Request From FTC On Pending Transaction
Saturday, 28 Sep 2019 

Sept 27 (Reuters) - Abbvie Inc ::ABBVIE AND ALLERGAN RECEIVE SECOND REQUEST FROM FEDERAL TRADE COMMISSION ON PENDING TRANSACTION.ABBVIE INC - CO AND ALLERGAN ARE COOPERATING FULLY WITH FTC AND CONTINUE TO EXPECT TO CLOSE TRANSACTION IN EARLY 2020.  Full Article

Evolus Expects 2019 Revenue To Be Back-loaded Towards Q4: Conf. Call
Monday, 12 Aug 2019 

Aug 12 (Reuters) - Evolus Inc ::SAYS OF CONSUMER SWITCH FROM OTHER TOXINS TO JEUVEAU, APPROXIMATELY 70% CAME FROM BOTOX COSMETICS: CONF. CALL.SAYS EXPECTS 2019 REVENUE TO BE BACKLOADED TOWARDS THE FOURTH QUARTER.  Full Article

UPDATE 2-AbbVie raises profit outlook on Botox recovery signs, new drugs growth

Oct 30 Drugmaker AbbVie Inc raised its full-year profit forecast on Friday, bolstered by signs of recovery in demand for its Botox injection on easing COVID-19 restrictions and strong growth for its latest drugs, sending its shares up 6%.

No consensus analysis data available.